Sagent Pharmaceuticals Inc (NASDAQ:SGNT), saw an insider increase his position with the company. Chief Legal Officer Michael Logerfo acquired 12,759 shares of common stock at an average price of $4.31 per share. Following this transaction, Logerfo now directly holds 45,770 shares while indirectly having 1,000 shares invested in the company.
A $411.35 million market cap company, Sagent Pharmaceuticals Inc (NASDAQ:SGNT) is an injectable pharmaceutical company, which develops and sources products, which the Company sells in the United States. The Company offers its customers a range of products across anti-infective, oncolytic and critical care indications in a range of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it focuses to develop injectable products.
In addition, the hedge fund with the most involvement in the company is Sectoral Asset Management. The fund, run by Jerome Pfund And Michael Sjostrom rose its activity by 51% last quarter and now holds 1,038,504 shares worth about $24.3 million.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.